These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36523121)

  • 1. Bilateral breast multiple myeloma: a case report.
    Mo CKM; Lai AYT; Lo SSW; Wong TS; Wong WWC
    Hong Kong Med J; 2022 Dec; 28(6):488-490. PubMed ID: 36523121
    [No Abstract]   [Full Text] [Related]  

  • 2. Nuclear imaging in breast cancer.
    Ferrara A
    Radiol Technol; 2010; 81(3):233-46. PubMed ID: 20051596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected focal hypermetabolic activity in the breast: significance in patients undergoing 18F-FDG PET/CT.
    Korn RL; Yost AM; May CC; Kovalsky ER; Orth KM; Layton TA; Drumm D
    AJR Am J Roentgenol; 2006 Jul; 187(1):81-5. PubMed ID: 16794159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and follow-up with 18F-fluorodeoxiglucose positron emission tomography/computed tomography of extraosseous myeloma].
    Garcia JR; Canales M; Ponce A; Buxeda M; Moragas M; Soler M
    Rev Esp Med Nucl Imagen Mol; 2014; 33(2):115-7. PubMed ID: 23867637
    [No Abstract]   [Full Text] [Related]  

  • 5. Case 256: Breast Implant-associated Anaplastic Large-Cell Lymphoma.
    Eisenberg AM; Eppelheimer CN; Fulop TA; Abramson LL
    Radiology; 2018 Aug; 288(2):624-629. PubMed ID: 30020870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose transporter expression of intraductal papilloma of the breast detected by fluorodeoxyglucose positron emission tomography.
    Hirose Y; Kaida H; Ishibashi M; Kawahara A; Kobayashi M; Hayabuchi N
    Jpn J Radiol; 2011 Apr; 29(3):217-21. PubMed ID: 21519997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG.
    Murthy K; Aznar M; Thompson CJ; Loutfi A; Lisbona R; Gagnon JH
    J Nucl Med; 2000 Nov; 41(11):1851-8. PubMed ID: 11079494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Role of Fluorodeoxyglucose PET in Breast Cancer: A History to Current Application.
    Chakraborty D; Basu S; Ulaner GA; Alavi A; Kumar R
    PET Clin; 2018 Jul; 13(3):355-361. PubMed ID: 30100075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse intense 18F-FDG uptake at PET in unilateral breast related to breastfeeding practice.
    Ko KH; Jung HK; Jeon TJ
    Korean J Radiol; 2013; 14(3):400-2. PubMed ID: 23690704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modern imaging of multiple myeloma.
    Seppanen M
    Acta Radiol; 2008 Jun; 49(5):487-8. PubMed ID: 18568530
    [No Abstract]   [Full Text] [Related]  

  • 11. Positron Emission Tomography (PET) and Mammography (PEM) for breast cancer: importance to surgeons.
    Tafra L
    Ann Surg Oncol; 2007 Jan; 14(1):3-13. PubMed ID: 17066235
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic Value of Nineteen Different Imaging Methods for Patients with Breast Cancer: a Network Meta-Analysis.
    Zhang XH; Xiao C
    Cell Physiol Biochem; 2018; 46(5):2041-2055. PubMed ID: 29723846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of positron emission tomography/computed tomography in breast cancer.
    Bourgeois AC; Warren LA; Chang TT; Embry S; Hudson K; Bradley YC
    Radiol Clin North Am; 2013 Sep; 51(5):781-98. PubMed ID: 24010906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET: A Prospective Observational Study.
    Noritake M; Narui K; Kaneta T; Sugae S; Sakamaki K; Inoue T; Ishikawa T
    Clin Nucl Med; 2017 Mar; 42(3):169-175. PubMed ID: 28072617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
    Ng SP; David S; Alamgeer M; Ganju V
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear imaging and early breast cancer detection.
    Evangelista L; Cervino AR
    Curr Radiopharm; 2014; 7(1):29-35. PubMed ID: 24836945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Imaging methods in the current diagnosis of and screening for breast cancer].
    Forrai G; Szabó E; Ormándi K; Ambrózay E; Péntek Z; Milics M; Rajtár M; Sinkovics I
    Magy Onkol; 2010 Sep; 54(3):211-6. PubMed ID: 20870598
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical contribution of PET/CT in myeloma: from the perspective of a radiologist.
    Nakamoto Y
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):10-1. PubMed ID: 24461803
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular Imaging and Its Role in the Management of Breast Cancer.
    Kiser J
    Clin Obstet Gynecol; 2016 Jun; 59(2):403-11. PubMed ID: 26982254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging.
    Avril N; Adler LP
    Radiol Clin North Am; 2007 Jul; 45(4):645-57, vi. PubMed ID: 17706529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.